Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc

Decompensated liver cirrhosis has a dismal prognosis, with patients surviving on average for 2–4 years after the first diagnosis of ascites. Albumin is an important tool in the therapy of cirrhotic ascites. By virtue of its oncotic properties, it reduces the risk of cardiovascular dysfunction after...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kurt Grüngreiff, Thomas Gottstein, Dirk Reinhold, Claudia A. Blindauer
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/a20f9cfe3ead4174bc1a66af0e573311
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!